References
Farmacotherapeutisch Kompas (2010). Available at: http://www.fk.cvz.nl. Accessed 24 Oct 2010
College ter Beoordeling van Geneesmiddelen (Medicines Evaluation Board). Part 1B—Summary of product characteristics. Available at: http://www.cbg-meb.nl. Accessed 26 Oct 2010
Thomson Micromedex. Micromedex Healthcare Series (database online). Thomson Micromedex, Greenwood Village, Colorado. Available at: http://www.thomsonhc.com. Accessed 24 Oct 2010
Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP). KNMP Kennisdatabank (database online). Available at: http://www.kennisbank.knmp.nl/home.asp. Accessed 24 Oct 2010
Netherlands Pharmacovigilance Centre Lareb. Interaction database of the Netherlands Pharmacovigilance Centre Lareb. Available at: http://www.lareb.nl/bijwerkingen/zoekgeneesmiddel.asp. Accessed 26 Oct 2010
Baxter K (2006) Stockley’s drug interactions, 7th edn. Wolters Kluwer, Alphen aan den Rijn
PubMed. Available at: http://www.ncbi.nlm.nih.gov. Accessed 24 Oct 2010
Aronson JK (2006) Meyler's side effects of drugs, 15th edn. Elsevier, Amsterdam
Indiana University, Division of Clinical Pharmacology. Database online. P450 drug interaction table. Available at: http://medicine.iupui.edu/clinpharm/DDIs/table.asp. Accessed 31 Oct 2010
Schalekamp T, Van den Brink G (2003) Farmacokinetiek en interacties: het belang van inzicht. Pharmaceut Weekbl 138(22):787–92. Available at: http://igitur-archive.library.uu.nl/phar/2008-0519-201420/schalekamp_03_hetbelangvaninzicht.pdf
You G, Morris ME (2007) Drug transporters: molecular characterization and role in drug disposition. Wiley, New York
Collett A, Tanianis-Hughes J, Warhurst G (2004) Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions? Biochem Pharmacol 68(4):783–790
Yu DK (1999) The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions. J Clin Pharmacol 39(12):1203–1211
Huwyler J, Wright MB, Gutmann H, Drewe J (2006) Induction of cytochrome P450 3A4 and P-glycoprotein by the isoxazolyl-penicillin antibiotic flucloxacillin. Curr Drug Metab 7(2):119–126
Huwyler J, Wright MB, Gutmann H, Drewe J (2006) Induction of cytochrome P450 3A4 and P-glycoprotein by the isoxazolylpenicillin antibiotic flucloxacillin. Curr Drug Metabol 7:119–126
Cynke E, Binet I, Haefeli WE, Thiel G (1999) Flucloxacillin & cyclosporine A: an unrecognised but relevant interaction in renal transplant recipients. Kidney Intern 55:1156–1157
Acknowledgments
We would like to thank Tom Schalekamp, PharmD, PhD, Associate Professor of Pharmacotherapy at Utrecht University, the Netherlands, for his knowledge and thoughts on the subject of this article.
Conflict of Interest
None.
Financial statement
The authors received no financial support for this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Comuth, W.J., Comuth, J.A., Hauer, R.N.W. et al. Interaction of flucloxacillin and quinidine. Eur J Clin Pharmacol 68, 891–893 (2012). https://doi.org/10.1007/s00228-011-1179-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-011-1179-0